VENTURA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.910
EU - Europa 18.467
AS - Asia 10.638
SA - Sud America 1.631
Continente sconosciuto - Info sul continente non disponibili 300
AF - Africa 225
OC - Oceania 44
Totale 58.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.247
IT - Italia 6.196
GB - Regno Unito 4.911
SG - Singapore 3.061
SE - Svezia 2.836
CN - Cina 2.831
BR - Brasile 1.239
HK - Hong Kong 1.153
DE - Germania 1.085
VN - Vietnam 1.070
BD - Bangladesh 668
FR - Francia 638
FI - Finlandia 637
UA - Ucraina 571
TR - Turchia 403
RU - Federazione Russa 401
CA - Canada 371
KR - Corea 353
NL - Olanda 323
IN - India 293
BG - Bulgaria 179
ID - Indonesia 150
AR - Argentina 136
MX - Messico 114
PL - Polonia 111
IQ - Iraq 91
JP - Giappone 91
BE - Belgio 82
ZA - Sudafrica 80
ES - Italia 75
IE - Irlanda 72
MY - Malesia 62
CO - Colombia 57
AE - Emirati Arabi Uniti 54
EC - Ecuador 51
CL - Cile 44
RO - Romania 44
CH - Svizzera 43
LT - Lituania 41
VE - Venezuela 39
AU - Australia 37
CR - Costa Rica 37
AT - Austria 36
CZ - Repubblica Ceca 36
PH - Filippine 36
PK - Pakistan 32
UZ - Uzbekistan 30
SA - Arabia Saudita 29
JM - Giamaica 26
IL - Israele 25
IR - Iran 23
JO - Giordania 23
PE - Perù 23
MA - Marocco 22
AZ - Azerbaigian 21
PY - Paraguay 21
PT - Portogallo 20
TT - Trinidad e Tobago 20
DZ - Algeria 19
EG - Egitto 19
GR - Grecia 19
NP - Nepal 19
HN - Honduras 17
NO - Norvegia 17
TH - Thailandia 17
TN - Tunisia 17
GT - Guatemala 15
KE - Kenya 15
TW - Taiwan 15
NI - Nicaragua 14
AL - Albania 12
BO - Bolivia 12
EU - Europa 12
KG - Kirghizistan 11
BH - Bahrain 10
DK - Danimarca 9
EE - Estonia 9
PR - Porto Rico 9
RS - Serbia 9
SY - Repubblica araba siriana 9
DO - Repubblica Dominicana 8
SC - Seychelles 8
SV - El Salvador 8
AM - Armenia 7
BY - Bielorussia 7
CY - Cipro 7
ET - Etiopia 7
MD - Moldavia 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
BB - Barbados 6
HU - Ungheria 6
KZ - Kazakistan 6
MK - Macedonia 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
LU - Lussemburgo 5
PA - Panama 5
PS - Palestinian Territory 5
Totale 57.836
Salva come PNG Salva come JPEG
Città #
Ashburn 4.009
Southend 3.859
Santa Clara 2.044
Singapore 1.903
Stockholm 1.802
Fairfield 1.793
San Jose 1.355
Chandler 1.194
Hong Kong 1.130
Woodbridge 1.108
Houston 1.101
Hefei 930
Jacksonville 825
Council Bluffs 750
Ann Arbor 621
Seattle 620
Wilmington 601
Dearborn 574
Cambridge 570
London 563
Beijing 555
Nyköping 555
Helsinki 469
Los Angeles 453
Rome 442
Milan 426
Dallas 381
Chicago 377
Ho Chi Minh City 368
Seoul 337
New York 314
The Dalles 264
Modena 258
Hanoi 238
Berlin 212
São Paulo 199
Izmir 196
San Diego 191
Princeton 184
Sofia 169
Eugene 150
Munich 147
Lauterbourg 142
Buffalo 135
Toronto 123
Naples 118
Bologna 115
Moscow 115
Shanghai 111
Salt Lake City 110
Columbus 101
Orem 97
Phoenix 97
Boardman 95
Sunnyvale 91
Bremen 89
Jakarta 89
Des Moines 79
Parma 76
Frankfurt am Main 75
Palermo 74
Atlanta 73
Montreal 73
Warsaw 72
Florence 69
Brussels 68
Rimini 66
Denver 65
Tokyo 63
Verona 62
Turin 60
Amsterdam 56
Bari 54
Brooklyn 53
Redwood City 53
Boston 52
Catania 52
Chennai 52
San Francisco 51
Yalova 51
Dublin 49
Falls Church 49
Tampa 49
Da Nang 47
Rio de Janeiro 44
Mexico City 43
Haiphong 42
Johannesburg 41
Elk Grove Village 38
Fremont 38
Guangzhou 36
Manchester 36
Turku 35
Miami 34
Mumbai 34
Paris 34
Philadelphia 34
Washington 34
Maidenhead 32
Miano 32
Totale 38.095
Salva come PNG Salva come JPEG
Nome #
Effetti dell’insulina sui livelli di omocisteina plasmatica in pazienti con diabete mellito tipo ii con e senza intolleranza alla metionina 2.584
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.856
Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy 807
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 771
Oxford Manuale di Medicina Clinica 764
Validating the Body Uneasiness Test (BUT) in obese patients 740
Weight Loss Expectations in Obese Patients and Treatment Attrition: An Observational Multicenter Study 726
Trombosi portale e iperomocisteinemia in pazienti con cirrosi epatica 699
Isomeri urinari della Coproporfirina in pazienti con Epatopatie Colestatiche Acquisite e sindrome di Dubin-Johnson 661
Impiego dei marcatori di neoplasia (CEA, CA 19.9, CA 125, CA 16.3, NSE) in Medinina Interna: uno studio retrospettivo 603
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 554
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers 528
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 527
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 522
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 516
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics 506
Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers 490
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias 449
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 448
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 444
N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion 430
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 430
Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature 426
Acute Intermittent Porphyria in a Child with Severe Neuropathy 425
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 417
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects 402
The Acute Porphyric Attack: A Difficult Diagnosis for a Potential Lethal Event in Emergency Medicine 398
A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B-12 and folate deficiency: results from an in vitro experience 396
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks 389
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 386
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 383
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 370
Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network 368
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 363
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 361
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 357
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 352
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 352
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 351
Psychological Distress in Morbid Obesity in Relation to Weight History 350
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 348
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 347
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 346
Weight Loss Expectations in Obese Patients Seeking Treatment at Medical Centers 343
A large deletion on chromosome 11 in acute intermittent porphyria 342
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 339
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 336
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 334
Drugs and acute porphyrias: reasons for a hazardous relationship 333
Urinary coproporhyrin isomers during therapy with IFn-RIBA in patients with chronic hepatitis due to HCV infection 331
Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies 330
The Metabolic Syndrome in Treatment-Seeking Obese Persons 327
Anti- and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease 325
Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness 323
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 321
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 319
Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians 319
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 319
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 318
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study 318
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks 315
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP) 312
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 311
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 311
Radiofrequency ablation combined with transcatheter arterial chemioembolization in the treatment of advanced hepatocellular carcinoma 308
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 300
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 300
Insulin resistance in advanced liver cirrhosis : the role of liver dysfunction and the “dissociated” effect on glucose versus lipid and amino acid metabolism 300
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 299
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 299
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 297
Affinità dell'omocisteina per le lipoproteine 296
Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. 295
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 293
Markers of Endothelial Dysfunction in patients with liver cirrhosis with anh without portal hypertension 291
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization 290
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 289
Plasma nitric oxide production during acute hyperhomocysteinemia in atherosclerotic patients and controls 283
Hepatocellular carcinoma in HIV infected patients: check early, treat hard. 283
Porfiria acuta intermittente: un caso "eccezionale" 283
Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis 282
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria 281
The Effect of Obesity Management on Body Image in Patients Seeking Treatment at Medical Centers 280
Portal vein thrombosis and thrombophilia in liver cirrhosis: a role for hyperhomocysteinemia ? 280
Correlation between plasma malonyldialdeide levels and paroxonase activity in healthy subjects and in patients with atherosclerotic disease 279
Rilevanza del diverso contenuto apolipoproteico nel legame dell’omocisteina alle lipoproteine 279
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 279
Portal vein thrombosis and hyperhomocysteinemia in patients with liver cirrosis 276
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity 276
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats 275
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 275
Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report 274
I fattori di rischio cardiovascolare nell'anziano 274
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 274
Acute Hepatic Porphyrias: “Purple Flags”—Clinical Features that should Prompt Specific Diagnostic Testing 273
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins 272
Iron Metabolism in the Disorders of Heme Biosynthesis 269
Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding ? 266
Relevance of different apolipoprtein content in homocysteine binding to plasma lipoproteins 266
Serum HBsAg and ddPCR HBV-DNA as predictive parameters of HBsAg loss after nucleo(s)tide analogue (NA) treatment discontinuation in non-cirrhotic patients with Chronic Hepatitis B 261
Totale 40.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.789 0 0 0 308 143 217 211 219 407 316 538 430
2022/20234.119 423 420 318 370 452 551 118 389 491 112 229 246
2023/20242.739 168 179 241 227 399 196 225 336 115 124 192 337
2024/20258.142 322 149 325 583 1.543 1.083 598 494 885 337 858 965
2025/202617.715 1.010 748 1.368 1.491 1.785 1.117 1.782 828 3.445 1.625 1.487 1.029
2026/20276.649 1.008 1.438 1.668 2.535 0 0 0 0 0 0 0 0
Totale 58.215